Proton Pump Inhibitors, Antiglaucoma Meds Linked to Dry Eye
Despite prior suspicion, the review shows no link between dry eye disease and antidepressants or antihypertensives.
Antidepressants
A Multifactorial Approach to Treating Irritable Bowel Syndrome
Researchers provided practical tips and management approach strategies for the treatment of severe irritable bowel syndrome.
Antidepressant Use May Aid Outcomes in Depression and Diabetes
Regular antidepressant use is associated with a lower risk for diabetes complications among adults with depression and newly treated diabetes.
Venlafaxine More Effectively Treats Symptoms of Major Depressive Disorder After Menopause Than Fluoxetine
To date, there has not been proven evidence for serotonin-norepinephrine reuptake inhibitors over selective serotonin reuptake inhibitors in postmenopausal patients with major depressive disorder. Consequently, study researchers aimed to compare the efficacy and safety of venlafaxine vs fluoxetine in the treatment of postmenopausal MDD.
Medication Organizers Often Contain “One Pill Can Kill” Meds
While known to increase patient compliance, medication organizers, such as blister packs and pill boxes, have also been associated with unintentional pediatric medication exposures.
Meta-Analysis of Pharmacotherapy for Mental Health During Pregnancy
While mental health disorders are prevalent among pregnant women, limited research, with limited strength of evidence has examined the effectiveness, benefits, and harms of pharmacotherapy for perinatal mental health disorders. Consequently, the researchers systematically reviewed evidence of pharmacotherapy for perinatal mental health disorders.
Novel Biosensor Aids in the Discovery of a Psychedelic Drug Without Hallucinogenic Effects
To better understand the conformational effects of psychedelic compounds, researchers developed psychLight, a genetically encoded biosensor that generates fluorescence in 5-HT2AR.
Novel Glycine Transporter Inhibitor Gets Breakthrough Tx Status for Cognitive Impairment With Schizophrenia
The designation is based on results from a phase 2 trial that evaluated the efficacy and safety of 4 different doses of BI 425809 orally once daily in adults with CIAS for 12 weeks.
Staying on Antidepressants During Pregnancy Increases Risk of Obstetric Complications, Postpartum Psychiatric Disorders
Women who stopped antidepressant treatment during pregnancy and resumed in the following weeks had a rebound effect of increased prescription of benzodiazepines and anxiolytics.
Effect of Benzodiazepines on Esketamine Nasal Spray in Patients With Major Depressive Disorder and Suicidal Ideation
Post-hoc analyses of pooled data from the randomized, double-blind ASPIRE 1 and ASPIRE II studies were conducted to assess the effect of esketamine in adult patients with major depressive disorder and active suicidal ideation.
- Loading...
Loading...
Next post in Psych Congress 2020 Coverage
Loading... 
Loading...